ALPHAHELIX MOL.DIAGN. SK1 Capital Reinvestment Ratio

Latest as of December 2022: 0.10x

ALPHAHELIX MOL.DIAGN. SK1 capital reinvestment ratio. ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a Capital Reinvestment Ratio of 0.10x as of December 2022, meaning it reinvests 0% of its operating cash flow (€2.87 Million) in capital expenditures (€288.09K). Check ALPHAHELIX MOL.DIAGN. SK1 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.10x
Capex / Operating Cash Flow

Operating Cash Flow

€2.87 Million
EUR

Capital Expenditures

€288.09K
EUR

Data as of

Dec 2022
Most recent filing

Capital Reinvestment Ratio of ALPHAHELIX MOL.DIAGN. SK1 (2022–2022)

Capital reinvestment ratio of ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2022. This chart tracks ALPHAHELIX MOL.DIAGN. SK1's Capital Reinvestment Ratio across 1 annual periods. Also explore ALPHAHELIX MOL.DIAGN. SK1 (4MB) net asset momentum to track the company's year-over-year net asset growth rate.

ALPHAHELIX MOL.DIAGN. SK1 Capital Reinvestment Ratio by Year (2022–2022)

ALPHAHELIX MOL.DIAGN. SK1 capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see 4MB cash flow conversion.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2022 0.10x €2.87 Million €288.09K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow